Cardiovascular Outcomes – Pharmacy & Acute Care University

Marso SP, et al. “Liraglutide and cardiovascular outcomes in type 2 diabetes”. The New England Journal of Medicine. 2016. 375(4):311-322.

You are unauthorized to view this page.

Swedberg K, et al. “Treatment of anemia with darbepoetin alfa in systolic heart failure”. The New England Journal of Medicine. 2013. 368(13):1210-9.

You are unauthorized to view this page.

Bonaca MP, et al. “Long-term use of ticagrelor in patients with prior myocardial infarction”. The New England Journal of Medicine. 2015. 372(19):1791-1800.

You are unauthorized to view this page.

Tardif J, et al. “Efficacy and safety of low-dose colchicine after myocardial infarction”. The New England Journal of Medicine. 2019. 381(26):2497-2505.

You are unauthorized to view this page.

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

You are unauthorized to view this page.

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

You are unauthorized to view this page.

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

You are unauthorized to view this page.